Effects of isoflavones on behavior, estradiol, glutamate, and GABA levels in intact middle-aged female rats.

Objectives: Estrogen and phytoestrogens, mainly isoflavones (SIF) treatment has been suggested to improve mood, behavior, and cognitive function in postmenopausal women. However, there is a lack of information on the mechanism of such treatment on the central nervous system. We used rats to investigate the effects of long-term treatment with commercial isoflavones on behavior, hormones, and brain neurotransmitter levels. Methods: Intact female middle-aged (12 months) rats received 50, 100, and 200 mg/kg/day of commercial isoflavones extract by gavage for 90 days. After treatment, locomotor activity, anxiety-like behavior, spatial memory, estradiol, and neurotransmitter levels were measured. Results: Isoflavones treatment decreased total body weight gain in rats received 100 (P < 0.05) and 200 mg/kg (P < 0.05). There were no differences in locomotor activity or anxiety-like behavior; however, isoflavone treatment improved spatial memory (P < 0.05). Estradiol concentration was increased (P < 0.05) in groups SIF 100 and SIF 200. Glutamate (P < 0.01) and γ-aminobutyric acid (GABA) were increased in the prefrontal cortex (PFC) of rats receiving the highest doses and in the hypothalamus in rats that received SIF200 (P < 0.05). Discussion: These findings showed that long-term treatment with commercial isoflavones decreased total body weight gain and facilitated spatial memory performance in rats and this may be involved with the increase in estradiol levels as well as the increase in GABA and glutamate levels in PFC. Furthermore, isoflavones treatment may attenuate age-related cognitive impairment and may therefore be an effective tool to combat this undesirable feature of the natural aging process.

Effects of isoflavones on behavior, estradiol, glutamate, and GABA levels in intact middle-aged female rats

Objectives: Estrogen and phytoestrogens, mainly isoflavones (SIF) treatment has been suggested to improve mood, behavior, and cognitive function in postmenopausal women. However, there is a lack of information on the mechanism of such treatment on the central nervous system. We used rats to investigate the effects of long-term treatment with commercial isoflavones on behavior, hormones, and brain neurotransmitter levels. Methods: Intact female middle-aged (12 months) rats received 50, 100, and 200 mg/kg/day of commercial isoflavones extract by gavage for 90 days. After treatment, locomotor activity, anxiety-like behavior, spatial memory, estradiol, and neurotransmitter levels were measured. Results: Isoflavones treatment decreased total body weight gain in rats received 100 (P?<?0.05) and 200 mg/kg (P?<?0.05). There were no differences in locomotor activity or anxiety-like behavior; however, isoflavone treatment improved spatial memory (P?<?0.05). Estradiol concentration was increased (P?<?0.05) in groups SIF 100 and SIF 200. Glutamate (P?<?0.01) and ?-aminobutyric acid (GABA) were increased in the prefrontal cortex (PFC) of rats receiving the highest doses and in the hypothalamus in rats that received SIF200 (P?<?0.05). Discussion: These findings showed that long-term treatment with commercial isoflavones decreased total body weight gain and facilitated spatial memory performance in rats and this may be involved with the increase in estradiol levels as well as the increase in GABA and glutamate levels in PFC. Furthermore, isoflavones treatment may attenuate age-related cognitive impairment and may therefore be an effective tool to combat this undesirable feature of the natural aging process.

Effects of isoflavones on behavior, estradiol, glutamate, and GABA levels in intact middle-aged female rats

Objectives: Estrogen and phytoestrogens, mainly isoflavones (SIF) treatment has been suggested to improve mood, behavior, and cognitive function in postmenopausal women. However, there is a lack of information on the mechanism of such treatment on the central nervous system. We used rats to investigate the effects of long-term treatment with commercial isoflavones on behavior, hormones, and brain neurotransmitter levels. Methods: Intact female middle-aged (12 months) rats received 50, 100, and 200 mg/kg/day of commercial isoflavones extract by gavage for 90 days. After treatment, locomotor activity, anxiety-like behavior, spatial memory, estradiol, and neurotransmitter levels were measured. Results: Isoflavones treatment decreased total body weight gain in rats received 100 (P?<?0.05) and 200 mg/kg (P?<?0.05). There were no differences in locomotor activity or anxiety-like behavior; however, isoflavone treatment improved spatial memory (P?<?0.05). Estradiol concentration was increased (P?<?0.05) in groups SIF 100 and SIF 200. Glutamate (P?<?0.01) and ?-aminobutyric acid (GABA) were increased in the prefrontal cortex (PFC) of rats receiving the highest doses and in the hypothalamus in rats that received SIF200 (P?<?0.05). Discussion: These findings showed that long-term treatment with commercial isoflavones decreased total body weight gain and facilitated spatial memory performance in rats and this may be involved with the increase in estradiol levels as well as the increase in GABA and glutamate levels in PFC. Furthermore, isoflavones treatment may attenuate age-related cognitive impairment and may therefore be an effective tool to combat this undesirable feature of the natural aging process.

Preclinical study of an antiobesity herbal medicine, PholiaNegra (X´Tract Vetorized)TM, in male and female rats fed with high-fat diet: comparison with sibutramine / Estudo pré-clínico de um medicamento antiobesidade de ervas, PholiaNegra (X'Tract Vetorized)TM, em ratos machos e fêmeas alimentados com dieta hipercalórica: comparação com sibutramina

Objective - To assess, in this preclinical study, the effectiveness of a herbal medicine developed from a group of plants of the genus Ilexin the adjuvant treatment of obesity in rats fed with a high-fat diet. Phytotherapy is becoming increasingly popular both for the results it yields in several pathologies and because they are growing herbal medicine studies showing its effectiveness. Methods - Male and female rats were fed with a high-fat diet for one month. The diet was then replaced by a chow diet. All male and female rats received the PholiaNegra(X´Tract Vetorized)TM or water. The treatment was orally administered twice a day over 30 days. Body weight gain was assessed weekly and, at the end of treatment, the total body weight gain was calculated. A positive control with sibutramine (7.5 mg/kg, twice a day, orally, over 30 day was also included. Results - A significant reduction in weekly body weight gain, as well as in total weight gain, in both male and female rats after the herbal medicine administration. The index of body weight loss showed that PholiaNegra (X´TractVetorized)TM was more effective in reducing body weight in female than in male rats. The sibutramine treatment showed the same profile as PholiaNegra (X´Tract Vetorized)TM treatment. Conclusion - The present data indicate that PholiaNegra (X´Tract Vetorized)TM herbal medicine was effective in decreasing body weight in male and female rats submitted to a high-fat diet, and showed a similar profile to that of sibutramine.

Objetivo - Avaliar, neste estudo pré-clínico, a eficácia de um medicamento desenvolvido a partir de um grupo de plantas do gênero Ilex no tratamento adjuvante da obesidade em ratos alimentados com uma dieta hipercalórica. A fitoterapia está se tornando cada vez mais popular, tanto pelos resultados positivos em diversas doenças e porque estão crescendo estudos de medicina de ervas que mostram a sua eficácia. Métodos - Ratos machos e fêmeas foram alimentados com uma dieta rica em gordura durante um mês. A dieta foi então substituída por uma ração normal do biotério. Todos ratos e ratas foram tratado com PholiaNegra (X´Tract Vetorized)TM ou água. O tratamento foi administrado por via oral, duas vezes por dia durante 30 dias. O ganho de peso corporal foi avaliado semanalmente e, no final do tratamento, o ganho de peso total foi calculado. Como controle positivo empregou-se a sibutramina (7,5 mg/kg, duas vezes por dia, por via oral, durante 30 dias. Resultados - Observou-se redução significativa no ganho de peso corporal semanal, bem como do ganho de peso total, tanto nos ratos machos e fêmeas, após a administração do medicamento à base de plantas. O índice de perda de peso corporal mostrou que Pholia-Negra (X´Tract Vetorized)TM foi mais eficaz na redução do peso corporal nas fêmeas do que em ratos machos. O tratamento com sibutramina mostrou o mesmo perfil obtido com o tratamento com PholiaNegra (X´Tract Vetorized)TM. Conclusão - Os presentes dados indicam que PholiaNegra (X´Tract Vetorized)TM foi eficaz em diminuir o peso corporal em ratos machos e fêmeas submetidos a uma dieta rica em gordura,e mostrou um perfil semelhante ao da sibutramina.

Anti-nociceptive and anti-inflammatory actions of Nepeta cataria L.var. citriodora (Becker) Balb. essential oil in mice / Efeitos antinociceptivos e anti-inflamatórios do óleo essencial de Nepeta cataria L. var. citriodora (Becker) Balb. em camundongos

Objective - Nepeta cataria (catnip) is a plant used to treat human diseases and is also found in pet toys. This study was performed to analyze the anti-nociceptive and anti-inflammatory effects of N. cataria essential oil (NCEO) in female mice. Methods - Phytochemical analyses of NCEO were performed. In addition, female mice treated with the oil were observed in an open for its general activity and to investigate the dose and time responses. The anti-nociceptive effects were evaluated by tail immersion and acetic acid writhing reflex tests.The anti-inflammatory oil properties were investigated by the carrageenan-induced edema test. Results - The results showed that 0.0005 and 0.001 mL/kg i.p. doses of NCEO increased the general activity of female mice, and the 0.0005 mL/kg dose reduced their immobility. Moreover, NCEO (0.0005 mL/kg) has anti-nociceptive properties, as the treated animals exhibited an increased latency of tail withdrawal and reduced acetic acid-induced abdominal constrictions. Furthermore, NCEO (0.0005 mL/kg) presented peripheric anti-inflammatory properties by reducing the induced edema after carrageenan injection. Conclusions - These effects may be due to the nepetalactone trans-trans and trans-cis nepetalactone isomers, which were detected as the predominant active components in the phytochemical analysis. It was suggested that the main effect of NCEO occurs on the central nervous system mechanism of pain.

Objetivo - A Nepeta cataria (catnip) é uma planta utilizada para tratar doenças humanas e também é encontrada em brinquedos de animais de estimação. O objetivo deste estudo foi analisar os efeitos antinociceptivos e anti-inflamatório do óleo essencial de N. cataria (NCEO) em camundongos fêmeas. Métodos - A análise fitoquímica do NCEO foi realizada. Além disso, os animais que foram tratados como óleo e foram observados em um campo aberto para mensurar a sua atividade em geral e investigar a dose e tempo de respostas. Os efeitos antinociceptivos foram avaliados pelos testes de imersão da cauda e reflexo de contorções abdominais causadas pelo ácido acético. As propriedades anti-inflamatórias do óleo foram investigadas pelo teste de edema induzido por carragenina. Resultados - Os resultados mostraram que 0,0005 e 0,001mL/ kg doses ip. de NCEO aumentou a atividade geral de camundongos fêmeas, e dose de 0,0005 mL/kg reduziu sua imobilidade. Além disso, NCEO (0,0005 mL/kg), tem propriedades antinociceptiva, como os animais tratados apresentaram uma maior latência de retirada de cauda e reduziu as contorções abdominais induzidas pelo ácido acético. Além disso, NCEO (0,0005mL/kg) apresentou efeito periférico e propriedades anti-inflamatórias, reduzindo o edema induzido após a injeção de carragenina. Conclusões - Estes efeitos podem ser devido aos isômeros nepetalactone trans-trans e nepetalactone trans-cis, que foram detectados como os componentes ativos predominante na análise fitoquímica. Foi sugerido que o principal efeito da NCEO ocorre no mecanismo do sistema nervoso central da dor.